Astec Lifesciences (NSE:ASTEC) EV-to-EBIT : -72.24 (As of Jun. 03, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Astec Lifesciences's Enterprise Value is ₹26,384 Mil. Astec Lifesciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-365 Mil. Therefore, Astec Lifesciences's EV-to-EBIT for today is -72.24.

The historical rank and industry rank for Astec Lifesciences's EV-to-EBIT or its related term are showing as below:

NSE:ASTEC' s EV-to-EBIT Range Over the Past 10 Years
Min: -352.43 Med: 20.85 Max: 86.39
Current: -72.24

During the past 13 years, the highest EV-to-EBIT of Astec Lifesciences was 86.39. The lowest was -352.43. And the median was 20.85.

NSE:ASTEC's EV-to-EBIT is ranked worse than
100% of 185 companies
in the Agriculture industry
Industry Median: 13.7 vs NSE:ASTEC: -72.24

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Astec Lifesciences's Enterprise Value for the quarter that ended in Mar. 2024 was ₹25,829 Mil. Astec Lifesciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-365 Mil. Astec Lifesciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -1.41%.

Astec Lifesciences EV-to-EBIT Historical Data

The historical data trend for Astec Lifesciences's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astec Lifesciences EV-to-EBIT Chart

Astec Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-EBIT

Get a 7-Day Free Trial

11.58

22.94

28.62

54.90

-70.72

Astec Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															54.90	81.65	-342.97	-51.07	-70.72

Competitive Comparison of Astec Lifesciences's EV-to-EBIT

For the Agricultural Inputs subindustry, Astec Lifesciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astec Lifesciences's EV-to-EBIT Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's EV-to-EBIT falls into.

Astec Lifesciences EV-to-EBIT Calculation

Astec Lifesciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	26383.939	/	-365.221
	=	-72.24

Astec Lifesciences's current Enterprise Value is ₹26,384 Mil.
Astec Lifesciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-365 Mil.

Astec Lifesciences (NSE:ASTEC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Astec Lifesciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-365.221	/	25829.15754
	=	-1.41 %

Astec Lifesciences's Enterprise Value for the quarter that ended in Mar. 2024 was ₹25,829 Mil.
Astec Lifesciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-365 Mil.

Astec Lifesciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Astec Lifesciences (NSE:ASTEC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (NSE:ASTEC) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

533138:India

Address

Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079

Website

https://www.astecls.com

Astec Lifesciences Ltd is engaged in producing agrochemicals and pharmaceutical intermediates. The company's products include agrochemicals, such as Tebuconazole, Propiconazole, Hexaconazole, Difenoconazole, Epoxiconazole, Cyproconazole, Flutriafol, Tricyclazole, Metalaxyl and lambda-cyhalothrin, and intermediates. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences (NSE:ASTEC) Headlines

No Headlines